F-22 (drug)
| Clinical data | |
|---|---|
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO2 |
| Molar mass | 235.327 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
F-22, also known as 6-(2-aminopropyl)-2,2-dimethyl-5-methoxy-2,3-dihydrobenzofuran or as benzofuran-2,2-dimethyl-5-methoxy-6-(2-aminopropane), is a lesser-known psychoactive drug of the amphetamine and benzofuran families. F-22 was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 15 mg, and the duration unknown.[1] F-22 produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of F-22. F-22 is the derivative of 6-APDB with two methyl groups at the carbon 2 and a methoxy group at carbon 5 of the benzofuran core.
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
See also
References
- ^ a b c Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. F-22 Entry
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.